Ocugen Interest Income from 2010 to 2025

OCGN Stock

USD 0.83 0.05 5.68%

Ocugen Interest Income yearly trend continues to be very stable with very little volatility. Interest Income is likely to drop to about 13.7 K. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2010-12-31

Previous Quarter

14.5 K

Current Value

13.7 K

Quarterly Volatility

5.9 M

Credit Downgrade

Yuan Drop

Covid

Check Ocugen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ocugen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 582.4 K, Interest Expense of 4.2 M or Selling General Administrative of 38.6 M, as well as many indicators such as Price To Sales Ratio of 25.43, Dividend Yield of 0.0 or PTB Ratio of 3.27. Ocugen financial statements analysis is a perfect complement when working with Ocugen Valuation or Volatility modules.

Check out the analysis of Ocugen Correlation against competitors.

Latest Ocugen's Interest Income Growth Pattern

Below is the plot of the Interest Income of Ocugen Inc over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Ocugen's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ocugen's overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Ocugen Interest Income Regression Statistics

	Arithmetic Mean	2,287,667
	Geometric Mean	78,959
	Coefficient Of Variation	258.67
	Mean Deviation	3,725,333
	Median	133,000
	Standard Deviation	5,917,584
	Sample Variance	35T
	Range	20M
	R-Value	(0.04)
	Mean Square Error	37.5T
	R-Squared	0
	Significance	0.89
	Slope	(46,325)
	Total Sum of Squares	525.3T

Ocugen Interest Income History

	2025	13.7 K
	2024	14.5 K
	2021	16.1 K
	2020	1065.0
	2019	1214.0
	2018	20 M
	2017	1.3 M

Other Fundumenentals of Ocugen Inc

Net Interest Income

Ocugen Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Long Term Debt Total	Capital Surpluse	Short Term Debt	Property Plant Equipment	Net Tangible Assets	Deferred Long Term Liab	Short Long Term Debt	Short Term Investments	Net Invested Capital	Net Working Capital	Capital Stock	Treasury Stock	Net Receivables
Total Assets		0.88	-0.93	-0.42	0.76	-0.31	0.98	-0.36	0.66	0.5	0.51	0.48	0.43	-0.08	0.45	0.8	-0.35	-0.33	0.5	0.86	0.85	0.72	0.22	-0.16
Total Stockholder Equity	0.88		-0.85	-0.41	0.59	-0.72	0.88	-0.59	0.67	0.47	0.44	0.32	0.17	0.0	0.3	0.65	-0.51	-0.48	0.33	0.79	0.77	0.65	0.22	-0.25
Net Debt	-0.93	-0.85		0.22	-0.63	0.35	-0.97	0.27	-0.44	-0.25	-0.25	-0.31	-0.42	0.08	-0.18	-0.62	0.22	0.18	-0.42	-0.75	-0.83	-0.49	0.03	0.01
Retained Earnings	-0.42	-0.41	0.22		-0.42	0.17	-0.31	0.58	-0.6	-0.79	-0.52	-0.08	-0.52	-0.4	-0.64	-0.45	0.51	0.46	-0.15	-0.37	-0.27	-0.56	-0.46	0.45
Accounts Payable	0.76	0.59	-0.63	-0.42		-0.06	0.73	-0.2	0.41	0.53	0.4	0.28	0.34	-0.01	0.56	0.53	-0.16	-0.15	0.77	0.54	0.52	0.45	0.15	-0.12
Total Liab	-0.31	-0.72	0.35	0.17	-0.06		-0.35	0.66	-0.33	-0.14	-0.06	0.03	0.24	-0.12	0.15	-0.08	0.51	0.47	0.06	-0.31	-0.27	-0.25	-0.08	0.1
Total Current Assets	0.98	0.88	-0.97	-0.31	0.73	-0.35		-0.36	0.58	0.4	0.4	0.41	0.38	-0.07	0.31	0.72	-0.34	-0.31	0.52	0.85	0.89	0.62	0.1	-0.1
Intangible Assets	-0.36	-0.59	0.27	0.58	-0.2	0.66	-0.36		-0.6	-0.46	-0.24	0.03	0.09	-0.26	-0.08	-0.25	0.86	0.76	-0.07	-0.52	-0.44	-0.51	-0.26	0.28
Common Stock	0.66	0.67	-0.44	-0.6	0.41	-0.33	0.58	-0.6		0.8	0.89	0.61	0.02	0.09	0.61	0.84	-0.68	-0.7	0.16	0.83	0.68	0.95	0.59	-0.63
Current Deferred Revenue	0.5	0.47	-0.25	-0.79	0.53	-0.14	0.4	-0.46	0.8		0.8	0.42	0.27	0.5	0.71	0.66	-0.53	-0.56	0.28	0.59	0.47	0.72	0.59	-0.63
Long Term Debt	0.51	0.44	-0.25	-0.52	0.4	-0.06	0.4	-0.24	0.89	0.8		0.74	0.03	0.02	0.77	0.84	-0.39	-0.51	0.12	0.64	0.48	0.84	0.67	-0.71
Long Term Debt Total	0.48	0.32	-0.31	-0.08	0.28	0.03	0.41	0.03	0.61	0.42	0.74		0.06	-0.05	0.32	0.58	-0.22	-0.45	0.17	0.61	0.5	0.72	0.32	-0.15
Capital Surpluse	0.43	0.17	-0.42	-0.52	0.34	0.24	0.38	0.09	0.02	0.27	0.03	0.06		0.27	0.3	0.24	0.1	0.12	0.28	0.19	0.26	0.17	-0.04	0.18
Short Term Debt	-0.08	0.0	0.08	-0.4	-0.01	-0.12	-0.07	-0.26	0.09	0.5	0.02	-0.05	0.27		-0.13	-0.17	-0.3	-0.31	-0.08	0.02	0.02	0.0	0.08	-0.07
Property Plant Equipment	0.45	0.3	-0.18	-0.64	0.56	0.15	0.31	-0.08	0.61	0.71	0.77	0.32	0.3	-0.13		0.74	-0.06	-0.06	0.32	0.34	0.22	0.6	0.61	-0.64
Net Tangible Assets	0.8	0.65	-0.62	-0.45	0.53	-0.08	0.72	-0.25	0.84	0.66	0.84	0.58	0.24	-0.17	0.74		-0.29	-0.31	0.23	0.81	0.73	0.84	0.53	-0.57
Deferred Long Term Liab	-0.35	-0.51	0.22	0.51	-0.16	0.51	-0.34	0.86	-0.68	-0.53	-0.39	-0.22	0.1	-0.3	-0.06	-0.29		0.92	-0.1	-0.63	-0.52	-0.62	-0.3	0.27
Short Long Term Debt	-0.33	-0.48	0.18	0.46	-0.15	0.47	-0.31	0.76	-0.7	-0.56	-0.51	-0.45	0.12	-0.31	-0.06	-0.31	0.92		-0.1	-0.65	-0.54	-0.64	-0.29	0.28
Short Term Investments	0.5	0.33	-0.42	-0.15	0.77	0.06	0.52	-0.07	0.16	0.28	0.12	0.17	0.28	-0.08	0.32	0.23	-0.1	-0.1		0.41	0.47	0.22	-0.17	0.15
Net Invested Capital	0.86	0.79	-0.75	-0.37	0.54	-0.31	0.85	-0.52	0.83	0.59	0.64	0.61	0.19	0.02	0.34	0.81	-0.63	-0.65	0.41		0.96	0.84	0.27	-0.27
Net Working Capital	0.85	0.77	-0.83	-0.27	0.52	-0.27	0.89	-0.44	0.68	0.47	0.48	0.5	0.26	0.02	0.22	0.73	-0.52	-0.54	0.47	0.96		0.68	0.11	-0.19
Capital Stock	0.72	0.65	-0.49	-0.56	0.45	-0.25	0.62	-0.51	0.95	0.72	0.84	0.72	0.17	0.0	0.6	0.84	-0.62	-0.64	0.22	0.84	0.68		0.54	-0.41
Treasury Stock	0.22	0.22	0.03	-0.46	0.15	-0.08	0.1	-0.26	0.59	0.59	0.67	0.32	-0.04	0.08	0.61	0.53	-0.3	-0.29	-0.17	0.27	0.11	0.54		-0.79
Net Receivables	-0.16	-0.25	0.01	0.45	-0.12	0.1	-0.1	0.28	-0.63	-0.63	-0.71	-0.15	0.18	-0.07	-0.64	-0.57	0.27	0.28	0.15	-0.27	-0.19	-0.41	-0.79

Click cells to compare fundamentals

About Ocugen Financial Statements

Ocugen investors utilize fundamental indicators, such as Interest Income, to predict how Ocugen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Interest Income	14.5 K	13.7 K
Net Interest Income	-90.8 K	-95.4 K

When determining whether Ocugen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ocugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ocugen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ocugen Inc Stock:

How To Invest In Ocugen

Details

Is Ocugen Stock a good investment?

Details

What is Ocugen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Ocugen Correlation against competitors.

You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.19)

Revenue Per Share

0.018

Quarterly Revenue Growth

1.353

Return On Assets

(0.48)

Return On Equity

(1.03)

The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ocugen Interest Income from 2010 to 2025

Latest Ocugen's Interest Income Growth Pattern

Ocugen Interest Income Regression Statistics

Ocugen Interest Income History

Other Fundumenentals of Ocugen Inc

Ocugen Interest Income component correlations

About Ocugen Financial Statements

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY